172 related articles for article (PubMed ID: 32550014)
1. Antibody responses to the RTS,S/AS01
Sanchez L; Vidal M; Jairoce C; Aguilar R; Ubillos I; Cuamba I; Nhabomba AJ; Williams NA; Díez-Padrisa N; Cavanagh D; Angov E; Coppel RL; Gaur D; Beeson JG; Dutta S; Aide P; Campo JJ; Moncunill G; Dobaño C
NPJ Vaccines; 2020; 5():46. PubMed ID: 32550014
[TBL] [Abstract][Full Text] [Related]
2. Baseline exposure, antibody subclass, and hepatitis B response differentially affect malaria protective immunity following RTS,S/AS01E vaccination in African children.
Ubillos I; Ayestaran A; Nhabomba AJ; Dosoo D; Vidal M; Jiménez A; Jairoce C; Sanz H; Aguilar R; Williams NA; Díez-Padrisa N; Mpina M; Sorgho H; Agnandji ST; Kariuki S; Mordmüller B; Daubenberger C; Asante KP; Owusu-Agyei S; Sacarlal J; Aide P; Aponte JJ; Dutta S; Gyan B; Campo JJ; Valim C; Moncunill G; Dobaño C
BMC Med; 2018 Oct; 16(1):197. PubMed ID: 30376866
[TBL] [Abstract][Full Text] [Related]
3. Differential Patterns of IgG Subclass Responses to
Dobaño C; Santano R; Vidal M; Jiménez A; Jairoce C; Ubillos I; Dosoo D; Aguilar R; Williams NA; Díez-Padrisa N; Ayestaran A; Valim C; Asante KP; Owusu-Agyei S; Lanar D; Chauhan V; Chitnis C; Dutta S; Angov E; Gamain B; Coppel RL; Beeson JG; Reiling L; Gaur D; Cavanagh D; Gyan B; Nhabomba AJ; Campo JJ; Moncunill G
Front Immunol; 2019; 10():439. PubMed ID: 30930896
[TBL] [Abstract][Full Text] [Related]
4. RTS,S/AS01
Suau R; Vidal M; Aguilar R; Ruiz-Olalla G; Vázquez-Santiago M; Jairoce C; Nhabomba AJ; Gyan B; Dosoo D; Asante KP; Owusu-Agyei S; Campo JJ; Izquierdo L; Cavanagh D; Coppel RL; Chauhan V; Angov E; Dutta S; Gaur D; Beeson JG; Moncunill G; Dobaño C
Vaccine; 2021 Jan; 39(4):687-698. PubMed ID: 33358704
[TBL] [Abstract][Full Text] [Related]
5. RTS,S/AS01E immunization increases antibody responses to vaccine-unrelated Plasmodium falciparum antigens associated with protection against clinical malaria in African children: a case-control study.
Dobaño C; Ubillos I; Jairoce C; Gyan B; Vidal M; Jiménez A; Santano R; Dosoo D; Nhabomba AJ; Ayestaran A; Aguilar R; Williams NA; Díez-Padrisa N; Lanar D; Chauhan V; Chitnis C; Dutta S; Gaur D; Angov E; Asante KP; Owusu-Agyei S; Valim C; Gamain B; Coppel RL; Cavanagh D; Beeson JG; Campo JJ; Moncunill G
BMC Med; 2019 Aug; 17(1):157. PubMed ID: 31409398
[TBL] [Abstract][Full Text] [Related]
6. Induction and decay of functional complement-fixing antibodies by the RTS,S malaria vaccine in children, and a negative impact of malaria exposure.
Kurtovic L; Agius PA; Feng G; Drew DR; Ubillos I; Sacarlal J; Aponte JJ; Fowkes FJI; Dobaño C; Beeson JG
BMC Med; 2019 Feb; 17(1):45. PubMed ID: 30798787
[TBL] [Abstract][Full Text] [Related]
7. Strong off-target antibody reactivity to malarial antigens induced by RTS,S/AS01E vaccination is associated with protection.
Macià D; Campo JJ; Moncunill G; Jairoce C; Nhabomba AJ; Mpina M; Sorgho H; Dosoo D; Traore O; Kusi KA; Williams NA; Oberai A; Randall A; Sanz H; Valim C; Asante KP; Owusu-Agyei S; Tinto H; Agnandji ST; Kariuki S; Gyan B; Daubenberger C; Mordmüller B; Petrone P; Dobaño C
JCI Insight; 2022 May; 7(10):. PubMed ID: 35446785
[TBL] [Abstract][Full Text] [Related]
8. The Anti-Circumsporozoite Antibody Response of Children to Seasonal Vaccination With the RTS,S/AS01E Malaria Vaccine.
Sagara I; Zongo I; Cairns M; Yerbanga RS; Mahamar A; Nikièma F; Tapily A; Sompougdou F; Diarra M; Zoungrana C; Issiaka D; Haro A; Sanogo K; Aziz Sienou A; Kaya M; Traore S; Thera I; Diarra K; Dolo A; Kuepfer I; Snell P; Milligan P; Ockenhouse C; Ofori-Anyinam O; Tinto H; Djimde A; Ouedraogo JB; Dicko A; Chandramohan D; Greenwood B
Clin Infect Dis; 2022 Sep; 75(4):613-622. PubMed ID: 34894221
[TBL] [Abstract][Full Text] [Related]
9. Long-term immunogenicity and immune memory response to the hepatitis B antigen in the RTS,S/AS01
Valéa I; Adjei S; Usuf E; Traore O; Ansong D; Tinto H; Owusu Boateng H; Some AM; Buabeng P; Vekemans J; Kotey A; Vandoolaeghe P; Cullinane M; Traskine M; Ouedraogo F; Sambian D; Lievens M; Tahita MC; Jongert E; Lompo P; Idriss A; Borys D; Ouedraogo S; Prempeh F; Schuerman L; Sorgho H; Agbenyega T
Hum Vaccin Immunother; 2020 Jun; 16(6):1464-1470. PubMed ID: 31951771
[TBL] [Abstract][Full Text] [Related]
10. Safety and Immunogenicity of Seven Dosing Regimens of the Candidate RTS,S/AS01E Malaria Vaccine Integrated Within an Expanded Program on Immunization Regimen: A Phase II, Single-Center, Open, Controlled Trial in Infants in Malawi.
Witte D; Cunliffe NA; Turner AM; Ngulube E; Ofori-Anyinam O; Vekemans J; Chimpeni P; Lievens M; Wilson TP; Njiram'madzi J; Mendoza YG; Leach A
Pediatr Infect Dis J; 2018 May; 37(5):483-491. PubMed ID: 29432383
[TBL] [Abstract][Full Text] [Related]
11. The effect of immunization schedule with the malaria vaccine candidate RTS,S/AS01E on protective efficacy and anti-circumsporozoite protein antibody avidity in African infants.
Ajua A; Lell B; Agnandji ST; Asante KP; Owusu-Agyei S; Mwangoka G; Mpina M; Salim N; Tanner M; Abdulla S; Vekemans J; Jongert E; Lievens M; Cambron P; Ockenhouse CF; Kremsner PG; Mordmüller B
Malar J; 2015 Feb; 14():72. PubMed ID: 25885325
[TBL] [Abstract][Full Text] [Related]
12. A phase IIA extension study evaluating the effect of booster vaccination with a fractional dose of RTS,S/AS01
Moon JE; Greenleaf ME; Regules JA; Debois M; Duncan EH; Sedegah M; Chuang I; Lee CK; Sikaffy AK; Garver LS; Ivinson K; Angov E; Morelle D; Lievens M; Ockenhouse CF; Ngauy V; Ofori-Anyinam O;
Vaccine; 2021 Oct; 39(43):6398-6406. PubMed ID: 34593270
[TBL] [Abstract][Full Text] [Related]
13. Optimization of incubation conditions of Plasmodium falciparum antibody multiplex assays to measure IgG, IgG
Ubillos I; Jiménez A; Vidal M; Bowyer PW; Gaur D; Dutta S; Gamain B; Coppel R; Chauhan V; Lanar D; Chitnis C; Angov E; Beeson J; Cavanagh D; Campo JJ; Aguilar R; Dobaño C
Malar J; 2018 Jun; 17(1):219. PubMed ID: 29859096
[TBL] [Abstract][Full Text] [Related]
14. RTS,S/AS01E Malaria Vaccine Induces Memory and Polyfunctional T Cell Responses in a Pediatric African Phase III Trial.
Moncunill G; De Rosa SC; Ayestaran A; Nhabomba AJ; Mpina M; Cohen KW; Jairoce C; Rutishauser T; Campo JJ; Harezlak J; Sanz H; Díez-Padrisa N; Williams NA; Morris D; Aponte JJ; Valim C; Daubenberger C; Dobaño C; McElrath MJ
Front Immunol; 2017; 8():1008. PubMed ID: 28878775
[TBL] [Abstract][Full Text] [Related]
15. Seven-year kinetics of RTS, S/AS01-induced anti-CSP antibodies in young Kenyan children.
Mugo RM; Mwai K; Mwacharo J; Shee FM; Musyoki JN; Wambua J; Otieno E; Bejon P; Ndungu FM
Malar J; 2021 Dec; 20(1):452. PubMed ID: 34856981
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial.
Olotu A; Lusingu J; Leach A; Lievens M; Vekemans J; Msham S; Lang T; Gould J; Dubois MC; Jongert E; Vansadia P; Carter T; Njuguna P; Awuondo KO; Malabeja A; Abdul O; Gesase S; Mturi N; Drakeley CJ; Savarese B; Villafana T; Lapierre D; Ballou WR; Cohen J; Lemnge MM; Peshu N; Marsh K; Riley EM; von Seidlein L; Bejon P
Lancet Infect Dis; 2011 Feb; 11(2):102-9. PubMed ID: 21237715
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial.
Asante KP; Abdulla S; Agnandji S; Lyimo J; Vekemans J; Soulanoudjingar S; Owusu R; Shomari M; Leach A; Jongert E; Salim N; Fernandes JF; Dosoo D; Chikawe M; Issifou S; Osei-Kwakye K; Lievens M; Paricek M; Möller T; Apanga S; Mwangoka G; Dubois MC; Madi T; Kwara E; Minja R; Hounkpatin AB; Boahen O; Kayan K; Adjei G; Chandramohan D; Carter T; Vansadia P; Sillman M; Savarese B; Loucq C; Lapierre D; Greenwood B; Cohen J; Kremsner P; Owusu-Agyei S; Tanner M; Lell B
Lancet Infect Dis; 2011 Oct; 11(10):741-9. PubMed ID: 21782519
[TBL] [Abstract][Full Text] [Related]
18. Induction, decay, and determinants of functional antibodies following vaccination with the RTS,S malaria vaccine in young children.
Feng G; Kurtovic L; Agius PA; Aitken EH; Sacarlal J; Wines BD; Hogarth PM; Rogerson SJ; Fowkes FJI; Dobaño C; Beeson JG
BMC Med; 2022 Aug; 20(1):289. PubMed ID: 36002841
[TBL] [Abstract][Full Text] [Related]
19. Impact of the RTS,S malaria vaccine candidate on naturally acquired antibody responses to multiple asexual blood stage antigens.
Campo JJ; Dobaño C; Sacarlal J; Guinovart C; Mayor A; Angov E; Dutta S; Chitnis C; Macete E; Aponte JJ; Alonso PL
PLoS One; 2011; 6(10):e25779. PubMed ID: 22022448
[TBL] [Abstract][Full Text] [Related]
20. Duration of vaccine efficacy against malaria: 5th year of follow-up in children vaccinated with RTS,S/AS02 in Mozambique.
Campo JJ; Sacarlal J; Aponte JJ; Aide P; Nhabomba AJ; Dobaño C; Alonso PL
Vaccine; 2014 Apr; 32(19):2209-16. PubMed ID: 24631081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
